• Chief executive officer of Novo Holdings A/S.
  • Member of the board of directors of Novozymes A/S.  

  • Managing director, co-head of Europe and member of the global management committee of Moelis & Co., 2009-2016.
  • Managing director and head of Financial Solutions Group of SUN Group, 2007-2009.
  • Positions at Morgan Stanley, including chair of the European Healthcare Group, 1989-2007.
  • Member of the board of trustees of Northwick Park Institute for Medical Research, 2005-2016. 
  • Member of the board of governors (2006-2011) and the investment committee (2011-2016) of the School of Oriental and African Studies (SOAS).

  • Not considered independent under the Danish Corporate Governance Recommendations.
  • Member of the Board of Directors since March 2017. Most recently elected in 2023 for a term of one year.
  • Member of the Nomination Committee since March 2017.
  • Member of the Research & Development Committee since March 2020.

  • Global corporate leadership.
  • Healthcare and pharma industry.
  • Finance & accounting.
  • Business development, M&A and external innovation sourcing.
  • Human capital management.

  • 1987: MSc in Economics, the London School of Economics, UK.
  • 1987: BSc in Economics, the London School of Economics, UK.

British, born 1965. Male.